4,766,072 has been issued to Promega Corporation for transcription vectors having two different bacteriophage RNA polymerase promoter sequences separated by a series of unique restriction sites into which foreign DNA can be inserted. No. 5,487,993 and European Pat. Inhibitors of Angiogenin , which comprises a segment of human PRI, is the subject of U.S. Pat. 1998 Promega Corporation. All Rights Reserved.
Product claims are subject to change.
Go to Promega Notes Magazine Index.